Saturday, January 28, 2023

Covovax

Govt panel recommends market clearance to Covovax as booster

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, PTI...

Panel approves use of Covovax for 7-11 year olds

An expert panel of India’s central drug authority on Friday recommended granting emergency use authorisation to Serum Institute’s Covovax for children aged 7 to 11 years, official sources said.The recommendation has been sent to Drugs Controller General of India...

SII lowers price of each doseof Covovax jab

A day after its Covid shot Covovax was included on the CoWIN portal for inoculation of children aged 12-17 years at private vaccination centres, the Serum Institute of India (SII) on Tuesday reduced the price of each dose of...

NTAGI recommends Covovax for 12-17 yrs

Standing Technical Sub-Committee of NTAGI has recommended inclusion of Serum Institute’s Covovax in the national anti-coronavirus vaccination programme for children aged 12 to 17 years, sources said on Friday.NTAGI panel, at its meeting on Friday, also discussed reducing the...

Govt panel recommends Covovax for all above 12

The Covid-19 Working Group of the NTAGI has recommended inclusion of the Serum Institute of India’s (SII) Covovax in the national vaccination programme for those aged 12 years and above, official sources said on Sunday.India’s drug regulator had approved...